Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes

Blood
Béatrice ClémenceauHenri Vié

Abstract

In the context of transplantation, donor and virus-specific T-lymphocyte infusions have demonstrated the dramatic potential of T cells as immune effectors. Unfortunately, most attempts to exploit the T-cell immune system against nonviral malignancies in the syngeneic setting have been disappointing. In contrast, treatments based on monoclonal antibodies (Abs) have been clinically successful and have demonstrated the clinical relevance of several antigens as therapeutic targets and the importance of the antibody-dependent cellular cytotoxicity (ADCC) pathway. In the present study, we considered the possibility of arming specific T cells with a receptor that would enable them to mediate ADCC. After transduction with a CD16/gamma receptor gene, CD4(+) and CD8(+) cytotoxic T lymphocytes displayed stable expression of the CD16 receptor at their surface. In the absence of Ab, CD16/gamma expression did not affect the capacity of specific T lymphocytes to kill their target following "natural" T-cell receptor recognition. When tested against the autologous B-lymphoblastoid cell line (BLCL) coated with anti-CD20 mAb, the newly expressed Fc receptor enabled the T cells to kill the BLCL through ADCC. Adoptive transfer of such newly designe...Continue Reading

References

Jan 1, 1975·European Journal of Immunology·M FerrariniM L Durante
May 1, 1992·The Journal of Experimental Medicine·U WirthmuellerJ V Ravetch
Nov 1, 1992·International Immunology·E VivierP Anderson
Dec 2, 1985·Klinische Wochenschrift·R E SchmidtJ Ritz
Jul 1, 1986·The Journal of Experimental Medicine·R E SchmidtJ Ritz
Apr 1, 1980·The Journal of Experimental Medicine·E L ReinherzS F Schlossman
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·B A BunnellR A Morgan
Dec 13, 1997·Hematology and Cell Therapy·C Bonini, C Bordignon
Oct 10, 1998·Journal of Virology·T DullL Naldini
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·C IbischH Vié
Oct 18, 2002·Cancer Immunology, Immunotherapy : CII·Nathalie LabarrièreFrancine Jotereau
Oct 18, 2002·Cancer Immunology, Immunotherapy : CII·Brigitte DrénoFrancine Jotereau
Jun 24, 2003·Drug Discovery Today·Martin J Glennie, Jan G J van de Winkel
Sep 6, 2003·Blood·Hans-Jochem KolbDolores J Schendel
Jun 9, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Wendy B BernsteinBruce L Levine

❮ Previous
Next ❯

Citations

Sep 20, 2012·Cancer Biotherapy & Radiopharmaceuticals·Wang-Xiong HuHong-Zhi Li
Oct 21, 2006·Human Gene Therapy·Michele W L TengPhillip K Darcy
Mar 1, 2012·BMC Proceedings·Laurent Bretaudeau, Véronique Bonnaudet
Oct 2, 2012·Journal of Immunological Methods·Eugenia Corrales-AguilarHartmut Hengel
Apr 30, 2016·Journal of Reproductive Immunology·Samira HosseiniAmir-Hassan Zarnani
May 11, 2016·Journal of Cellular Physiology·Albert T GacerezCharles L Sentman
Feb 17, 2018·Cell Death & Disease·Maria Michela D'AloiaMaurizio Alimandi
Aug 10, 2019·International Journal of Cancer. Journal International Du Cancer·Roberto ArrigaGiuseppe Sconocchia
Sep 4, 2019·International Journal of Cancer. Journal International Du Cancer·Sara CaratelliGiuseppe Sconocchia
Oct 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Denis HudrisierHenri Vié
May 28, 2020·Cancers·Claudia ArndtMichael Bachmann
Apr 20, 2019·International Journal of Molecular Sciences·Benedetto SacchettiMaurizio Alimandi
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Niklas K BjörkströmHans-Gustaf Ljunggren
May 13, 2017·Frontiers in Immunology·Sara CaratelliGiuseppe Sconocchia
Jan 2, 2020·International Journal of Molecular Sciences·Hannah E Hughes-ParryMisty R Jenkins
Dec 18, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laurie LajoieGilles Thibault
Apr 16, 2019·Frontiers in Oncology·Nicholas G MinutoloDaniel J Powell
Mar 28, 2019·Frontiers in Oncology·Nirav N ShahBryon Johnson
Nov 20, 2020·International Journal of Molecular Sciences·Alain E AndreaSalima Hacein-Bey-Abina
Feb 17, 2021·Nature Protocols·Stefan KiesgenPrasad S Adusumilli
May 25, 2021·Medicinal Research Reviews·Heleen HanssensNick Devoogdt
Nov 10, 2020·Cell Reports Medicine·Suzanne N MartosDouglas A Bell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.